{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T19:34:33Z","timestamp":1787686473558,"version":"build-2784847793"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170863"],"award-info":[{"award-number":["82170863"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA0804800"],"award-info":[{"award-number":["2021YFA0804800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800600"],"award-info":[{"award-number":["2018YFA0800600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Municipal Commission of Science and Technology","award":["20410713200"],"award-info":[{"award-number":["20410713200"]}]},{"name":"Shanghai Municipal Commission of Science and Technology","award":["21S11909000"],"award-info":[{"award-number":["21S11909000"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonalcoholic steatohepatitis (NASH) is a condition that progresses from nonalcoholic fatty liver disease (NAFLD) and is characterized by hepatic fat accumulation, inflammation, and fibrosis. It has the potential to develop into cirrhosis and liver cancer, and currently no effective pharmacological treatment is available. In this study, we investigate the therapeutic potential of targeting ceruloplasmin (Cp), a copper-containing protein predominantly secreted by hepatocytes, for treating NASH. Our result show that hepatic Cp is remarkedly upregulated in individuals with NASH and the mouse NASH model. Hepatocyte-specific Cp ablation effectively attenuates the onset of dietary-induced NASH by decreasing lipid accumulation, curbing inflammation, mitigating fibrosis, and ameliorating liver damage. By employing transcriptomics and metabolomics approaches, we have discovered that hepatic deletion of Cp brings about remarkable restoration of bile acid (BA) metabolism during NASH. Hepatic deletion of Cp effectively remodels BA metabolism by upregulating Cyp7a1 and Cyp8b1, which subsequently leads to enhanced BA synthesis and notable alterations in BA profiles. In conclusion, our studies elucidate the crucial involvement of Cp in NASH, highlighting its significance as a promising therapeutic target for the treatment of this disease.<\/jats:p>","DOI":"10.1093\/jmcb\/mjad060","type":"journal-article","created":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T08:33:04Z","timestamp":1695803584000},"source":"Crossref","is-referenced-by-count":13,"title":["Targeting hepatic ceruloplasmin mitigates nonalcoholic steatohepatitis by modulating bile acid metabolism"],"prefix":"10.1093","volume":"15","author":[{"given":"Quanxin","family":"Jiang","sequence":"first","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Lu","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Shanghai Diabetes Institute, Department of Endocrinology and Metabolism, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200233 , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"2024062709001957000_bib1","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/ajg.2010.170","article-title":"A role for low hepatic copper concentrations in nonalcoholic fatty liver disease","volume":"105","author":"Aigner","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"2024062709001957000_bib2","doi-asserted-by":"crossref","first-page":"129979","DOI":"10.1016\/j.bbagen.2021.129979","article-title":"Copper and lipid metabolism: a reciprocal relationship","volume":"1865","author":"Blades","year":"2021","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"2024062709001957000_bib3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","article-title":"Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis","volume":"69","author":"Brandl","year":"2018","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cmet.2021.02.007","article-title":"The phytochemical hyperforin triggers thermogenesis in adipose tissue via a Dlat\u2013AMPK signaling axis to curb obesity","volume":"33","author":"Chen","year":"2021","journal-title":"Cell Metab."},{"key":"2024062709001957000_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/CIRCULATIONAHA.122.058883","article-title":"Insulin and bile acids in cholesterol homeostasis: new players in diabetes-associated atherosclerosis","volume":"145","author":"Cortes","year":"2022","journal-title":"Circulation"},{"key":"2024062709001957000_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell Metab."},{"key":"2024062709001957000_bib8","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI117127","article-title":"Intact human ceruloplasmin oxidatively modifies low density lipoprotein","volume":"93","author":"Ehrenwald","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2024062709001957000_bib9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI118491","article-title":"Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells","volume":"97","author":"Ehrenwald","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2024062709001957000_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/diabetes.52.2.442","article-title":"Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study","volume":"52","author":"Engstrom","year":"2003","journal-title":"Diabetes"},{"key":"2024062709001957000_bib11","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(19)32963-0","article-title":"Obeticholic acid: towards first approval for NASH","volume":"394","author":"Eslam","year":"2019","journal-title":"Lancet"},{"key":"2024062709001957000_bib12","doi-asserted-by":"crossref","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","article-title":"Bile acids and their receptors in metabolic disorders","volume":"82","author":"Fiorucci","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"2024062709001957000_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41577-023-00889-3","article-title":"Copper boosts pro-inflammatory state of macrophages","volume":"23","author":"Flemming","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"2024062709001957000_bib14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0891-5849(00)00231-8","article-title":"Ceruloplasmin and cardiovascular disease","volume":"28","author":"Fox","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"2024062709001957000_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10620-016-4095-4","article-title":"Natural history of nonalcoholic fatty liver disease","volume":"61","author":"Goh","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"2024062709001957000_bib16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.cmet.2023.03.021","article-title":"Fructose-1,6-bisphosphatase is a nonenzymatic safety valve that curtails AKT activation to prevent insulin hyperresponsiveness","volume":"35","author":"Gu","year":"2023","journal-title":"Cell Metab."},{"key":"2024062709001957000_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-nutr-071812-161215","article-title":"Molecular mediators governing iron\u2013copper interactions","volume":"34","author":"Gulec","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"2024062709001957000_bib18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jn\/117.5.894","article-title":"Effect of zinc and copper deficiency on microsomal NADPH-dependent active oxygen generation in rat lung and liver","volume":"117","author":"Hammermueller","year":"1987","journal-title":"J. Nutr."},{"key":"2024062709001957000_bib19","doi-asserted-by":"crossref","first-page":"863296","DOI":"10.3389\/fmolb.2022.863296","article-title":"Fatty acid uptake in liver hepatocytes induces relocalization and sequestration of intracellular copper","volume":"9","author":"Harder","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"2024062709001957000_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.nutr.20.1.291","article-title":"Cellular copper transport and metabolism","volume":"20","author":"Harris","year":"2000","journal-title":"Annu. Rev. Nutr."},{"key":"2024062709001957000_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41591-023-02242-6","article-title":"Challenges and opportunities in NASH drug development","volume":"29","author":"Harrison","year":"2023","journal-title":"Nat. Med."},{"key":"2024062709001957000_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0168-8278(03)00078-3","article-title":"Iron overload, inflammation and fibrosis in genetic haemochromatosis","volume":"38","author":"Hubscher","year":"2003","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"2024062709001957000_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41401-022-00880-z","article-title":"Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease","volume":"43","author":"Jiao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"2024062709001957000_bib25","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(99)00219-6","article-title":"Serum aminotransferase concentration as evidence of hepatocellular damage","volume":"355","author":"Kew","year":"2000","journal-title":"Lancet"},{"key":"2024062709001957000_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1053\/meta.2002.33348","article-title":"Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study","volume":"51","author":"Kim","year":"2002","journal-title":"Metabolism"},{"key":"2024062709001957000_bib27","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/biomedicines9121903","article-title":"Hepatokines and non-alcoholic fatty liver disease: linking liver pathophysiology to metabolism","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"key":"2024062709001957000_bib28","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1039\/C6MT00103C","article-title":"Ceruloplasmin and other copper binding components of blood plasma and their functions: an update","volume":"8","author":"Linder","year":"2016","journal-title":"Metallomics"},{"key":"2024062709001957000_bib29","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"2024062709001957000_bib30","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/oxfordjournals.eurheartj.a060440","article-title":"Serum ferritin and ceruloplasmin as coronary risk factors","volume":"15","author":"M\u00e4ntt\u00e4ri","year":"1994","journal-title":"Eur. Heart J."},{"key":"2024062709001957000_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut\u2013liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib32","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2024062709001957000_bib33","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1021\/cr020443g","article-title":"Mechanism of oxidation reactions catalyzed by cytochrome p450 enzymes","volume":"104","author":"Meunier","year":"2004","journal-title":"Chem. Rev."},{"key":"2024062709001957000_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2024062709001957000_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41467-022-28889-2","article-title":"Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control","volume":"13","author":"Montgomery","year":"2022","journal-title":"Nat. Commun."},{"key":"2024062709001957000_bib36","doi-asserted-by":"crossref","first-page":"14773","DOI":"10.1074\/jbc.271.25.14773","article-title":"Ceruloplasmin enhances smooth muscle cell- and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism","volume":"271","author":"Mukhopadhyay","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2024062709001957000_bib37","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.pharmthera.2006.05.014","article-title":"Cytochrome P450s and cholesterol homeostasis","volume":"112","author":"Pikuleva","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"2024062709001957000_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jhep.2017.03.012","article-title":"Mice lacking liver-specific \u03b2-catenin develop steatohepatitis and fibrosis after iron overload","volume":"67","author":"Preziosi","year":"2017","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib39","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI106460","article-title":"The role of ceruloplasmin in iron metabolism","volume":"49","author":"Roeser","year":"1970","journal-title":"J. Clin. Invest."},{"key":"2024062709001957000_bib40","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1039\/C7MT00157F","article-title":"Rat ceruloplasmin: a new labile copper binding site and zinc\/copper mosaic","volume":"9","author":"Samygina","year":"2017","journal-title":"Metallomics"},{"key":"2024062709001957000_bib41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"2024062709001957000_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","article-title":"Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis","volume":"72","author":"Siddiqui","year":"2020","journal-title":"J. Hepatol."},{"key":"2024062709001957000_bib43","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease","volume":"94","author":"Sorbi","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"2024062709001957000_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"2024062709001957000_bib45","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/ijms19072140","article-title":"Effects and mechanism of nano-copper exposure on hepatic cytochrome P450 enzymes in rats","volume":"19","author":"Tang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"2024062709001957000_bib46","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/jn\/130.12.2915","article-title":"Copper deficiency induces hepatic fatty acid synthase gene transcription in rats by increasing the nuclear content of mature sterol regulatory element binding protein 1","volume":"130","author":"Tang","year":"2000","journal-title":"J. Nutr."},{"key":"2024062709001957000_bib47","doi-asserted-by":"crossref","first-page":"108457","DOI":"10.1016\/j.pharmthera.2023.108457","article-title":"Bile acid metabolism and signaling: emerging pharmacological targets of dietary polyphenols","volume":"248","author":"Tveter","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"2024062709001957000_bib48","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1042\/BST0380947","article-title":"Interactions of caeruloplasmin with other proteins participating in inflammation","volume":"38","author":"Vasilyev","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"2024062709001957000_bib49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"2024062709001957000_bib50","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.ebiom.2021.103290","article-title":"Conjugated secondary 12\u03b1-hydroxylated bile acids promote liver fibrogenesis","volume":"66","author":"Xie","year":"2021","journal-title":"EBioMedicine"},{"key":"2024062709001957000_bib51","doi-asserted-by":"crossref","first-page":"111498","DOI":"10.1016\/j.celrep.2022.111498","article-title":"Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1\u2013AMPK\u2013LKB1 complex","volume":"41","author":"Xie","year":"2022","journal-title":"Cell Rep."},{"key":"2024062709001957000_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2024062709001957000_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"2024062709001957000_bib54","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"2024062709001957000_bib55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm.4453","article-title":"The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat. Med."},{"key":"2024062709001957000_bib56","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"}],"container-title":["Journal of Molecular Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jmcb\/advance-article-pdf\/doi\/10.1093\/jmcb\/mjad060\/51792464\/mjad060.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jmcb\/article-pdf\/15\/9\/mjad060\/58344186\/mjad060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jmcb\/article-pdf\/15\/9\/mjad060\/58344186\/mjad060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T05:01:31Z","timestamp":1719464491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jmcb\/article\/doi\/10.1093\/jmcb\/mjad060\/7285809"}},"subtitle":[],"editor":[{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,4,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jmcb\/mjad060","relation":{},"ISSN":["1674-2788","1759-4685"],"issn-type":[{"value":"1674-2788","type":"print"},{"value":"1759-4685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9]]},"published":{"date-parts":[[2023,9]]},"article-number":"mjad060"}}